Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | Erlotinib | 0.31623 | uM | 9 | 312.50 | 153.73 | 317.00 | 266.25 | 1.1906 | 1.4926 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 309.00 | 266.25 | 1.1606 | 1.4135 | |
| BT-20 | Linsitinib | 19.9526 | uM | 9 | 312.50 | 153.73 | 119.00 | 266.25 | 0.4470 | -0.2761 |
| BT-20 | Linsitinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 319.00 | 266.25 | 1.1981 | 1.5124 |
| BT-20 | Erlotinib | 10 | uM | 9 | 312.50 | 153.73 | 248.00 | 266.25 | 0.9315 | 0.8286 |
| BT-20 | Erlotinib | 3.1623 | uM | 9 | 312.50 | 153.73 | 289.00 | 266.25 | 1.0854 | 1.2180 |
| BT-20 | 17-AAG | 0.0031623 | uM | 9 | 312.50 | 153.73 | 228.00 | 266.25 | 0.8563 | 0.6445 |
| BT-20 | Erlotinib | 0.01 | uM | 9 | 312.50 | 153.73 | 427.00 | 266.25 | 1.6038 | 2.6300 |
| BT-20 | Linsitinib | 0.01 | uM | 9 | 312.50 | 153.73 | 469.00 | 266.25 | 1.7615 | 3.0863 |
| BT-20 | 17-AAG | 0.0001 | uM | 9 | 312.50 | 153.73 | 393.00 | 266.25 | 1.4761 | 2.2691 |
| BT-20 | 17-AAG | 0.01 | uM | 9 | 312.50 | 153.73 | 174.00 | 266.25 | 0.6535 | 0.1692 |
| BT-20 | Linsitinib | 10 | uM | 9 | 312.50 | 153.73 | 180.00 | 266.25 | 0.6761 | 0.2203 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 265.00 | 266.25 | 0.9953 | 0.9882 | |
| BT-20 | Lapatinib | 1 | uM | 9 | 312.50 | 153.73 | 231.00 | 266.25 | 0.8676 | 0.6718 |
| BT-20 | Lapatinib | 10 | uM | 9 | 312.50 | 153.73 | 102.00 | 266.25 | 0.3831 | -0.4041 |
| BT-20 | Lapatinib | 0.0033113 | uM | 9 | 312.50 | 153.73 | 428.00 | 266.25 | 1.6075 | 2.6408 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 312.50 | 153.73 | 314.00 | 266.25 | 1.1793 | 1.4629 |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 381.00 | 266.25 | 1.4310 | 2.1437 |
| BT-20 | 17-AAG | 0.031623 | uM | 9 | 312.50 | 153.73 | 109.00 | 266.25 | 0.4094 | -0.3520 |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 230.00 | 266.25 | 0.8639 | 0.6627 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 758.00 | 736.00 | 1.0299 | 1.0496 | |
| BT-20 | 0 | uM | 9 | 625.00 | 320.09 | 685.00 | 736.00 | 0.9307 | 0.8839 | |
| BT-20 | Erlotinib | 0.0033113 | uM | 9 | 625.00 | 320.09 | 706.00 | 736.00 | 0.9592 | 0.9319 |
| BT-20 | 17-AAG | 0.001 | uM | 9 | 625.00 | 320.09 | 813.00 | 736.00 | 1.1046 | 1.1727 |
| BT-20 | 17-AAG | 0.000066069 | uM | 9 | 625.00 | 320.09 | 883.00 | 736.00 | 1.1997 | 1.3274 |